The FDA Peptide Ban is Ending — 11 Compounds Under Review
The FDA removed 11 peptides from the Category 2 Do-Not-Compound list on April 15, 2026. BPC-157, TB-500, MOTS-c and more are now under PCAC review. Here’s what it means.
The FDA removed 11 peptides from the Category 2 Do-Not-Compound list on April 15, 2026. BPC-157, TB-500, MOTS-c and more are now under PCAC review. Here’s what it means.
Wayne Stevenson analyzes CJC-1295 DAC vs. Tesamorelin: The Visceral Belly Fat Battle for metabolic health and muscle preservation.
I lost 48 pounds using Mounjaro, but what I discovered in the footnotes of the clinical trial data was alarming—severe lean mass wasting. Here is the 4-pillar prevention protocol I designed to lock in nitrogen balance, trigger protein synthesis, and protect structural strength.
The FDA removed 12 peptides from Category 2, but that does NOT mean they’re approved. Full regulatory breakdown of BPC-157, TB-500, and GHK-Cu status for 2026. Builder Blueprint case study by Wayne Stevenson.
Wayne Stevenson analyzes The Wolverine Stack: A Builders Case Study on BPC-157 + TB-500 for metabolic health and muscle preservation.
Wayne Stevenson analyzes I Lost 38 lbs on Mounjaro While Building Houses — My Complete 26-Week Protocol for metabolic health and muscle preservation.
Wayne Stevenson analyzes The Resonance Suite — 10 Healing Frequencies × Deep House for Body Recomposition & Focus for metabolic health and muscle preservation.
Wayne Stevenson analyzes GLP-1 Muscle Loss: Why It Happens and How to Prevent It for metabolic health and muscle preservation.
Wayne Stevenson analyzes GLP-1 Muscle Loss: The BPC-157 Recovery Protocol for Men Over 40 for metabolic health and muscle preservation.
Wayne Stevenson analyzes 7 Proven Secrets of the Wolverine Peptide Protocol for Elite Repair for metabolic health and muscle preservation.